Search hospitals > Pennsylvania > Philadelphia
Fox Chase Cancer Center
Claim this profilePhiladelphia, Pennsylvania 19111
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Pancreatic Cancer
Conducts research for Breast Cancer
Conducts research for Prostate Cancer
1153 reported clinical trials
68 medical researchers
Summary
Fox Chase Cancer Center is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Lung Cancer, Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer and other specialties. Fox Chase Cancer Center is involved with conducting 1,153 clinical trials across 671 conditions. There are 68 research doctors associated with this hospital, such as Anthony J. Olszanski, Jessica Bauman, MD, Margaret von Mehren, MD, and Deric C. Savior.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
2Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Anthony J. OlszanskiFox Chase Cancer Center4 years of reported clinical research
Expert in Solid Tumors
Studies Melanoma
17 reported clinical trials
24 drugs studied
Jessica Bauman, MDFox Chase Cancer Center4 years of reported clinical research
Studies Lung Cancer
Studies Solid Tumors
12 reported clinical trials
25 drugs studied
Margaret von Mehren, MDFox Chase Cancer Center4 years of reported clinical research
Studies Soft Tissue Sarcoma
Studies Cancer
12 reported clinical trials
45 drugs studied
Deric C. SaviorPaoli Memorial Hospital11 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
27 drugs studied
Clinical Trials running at Fox Chase Cancer Center
Lung Cancer
Cancer
Skin Cancer
Prostate Cancer
Bladder Cancer
Solid Tumors
Multiple Myeloma
Ovarian Cancer
Colorectal Cancer
Non-Small Cell Lung Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Fox Chase Cancer Center?
Fox Chase Cancer Center is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Lung Cancer, Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer and other specialties. Fox Chase Cancer Center is involved with conducting 1,153 clinical trials across 671 conditions. There are 68 research doctors associated with this hospital, such as Anthony J. Olszanski, Jessica Bauman, MD, Margaret von Mehren, MD, and Deric C. Savior.
Where is Fox Chase Cancer Center located?
**Fox Chase Cancer Center Location and Directions:**
- **Address:** 333 Cottman Avenue, Philadelphia, PA 19111.
- **By Car:** Accessible via I-76 E, exit 346A for PA-63 W towards Wynnefield.
- **Public Transportation:** Buses and trains serve the area, with detailed directions on the center's website.
Who should I call to ask about financial aid or insurance network?
**Fox Chase Cancer Center Financial Assistance and Insurance Information:**
- **Financial Assistance:** For charity care and other financial assistance, contact 888-336-5897 or visit the website. Financial counselors are available Monday through Friday, 8 am to 5 pm. For billing questions regarding hospital stays or services on or after October 1, 2022, call 888-336-5897. For services before this date, call 888-378-0357.
- **Insurance Inquiries:** Contact the Patient Financial Services Department at 888-366-5897 before your visit to confirm participation with your insurance.
- **Additional Support:** Temple Health hospitals, including Fox Chase Cancer Center, offer free or reduced-priced care for qualifying individuals and assistance with government-funded insurance programs and ACA Marketplace Plans.
What insurance does Fox Chase Cancer Center accept?
Fox Chase Cancer Center accepts a wide range of health insurance plans, such as Aetna, HMO, PPO, and POS. Patients are advised to contact their insurance company to understand their benefits and liabilities. This center stands out for accepting all insurance, ensuring broad access for patients.
What awards or recognition has Fox Chase Cancer Center received?
Fox Chase Cancer Center, located in Philadelphia, Pennsylvania, is a National Cancer Institute-designated Comprehensive Cancer Center renowned for its pioneering research and exceptional patient care. It has been honored with two Nobel Prizes, a Kyoto Prize, and a Lasker Prize, highlighting the significant achievements of its staff. Furthermore, it is recognized as one of the top cancer hospitals in the United States by U.S. News & World Report.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.